• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为微小RNA-217的靶点,Cullin 4B调节肾透明细胞癌中的细胞存活和凋亡。

Cullin 4B regulates cell survival and apoptosis in clear cell renal cell carcinoma as a target of microRNA-217.

作者信息

Yang Hai-Feng, Wang Zheng-Liang, Mao Ting-Ting, Liu Jian-Chang

机构信息

Department of Urology, Sunshine Union Hospital, Weifang, Shandong, China.

Department of Nephrology, Jimo District Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China.

出版信息

Kaohsiung J Med Sci. 2021 Feb;37(2):121-127. doi: 10.1002/kjm2.12307. Epub 2020 Oct 6.

DOI:10.1002/kjm2.12307
PMID:33022894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11896321/
Abstract

Cullin 4B (CUL4B) was reported to be closely related to the progression of some tumors, but its function in clear cell renal cell carcinoma (ccRCC) has not been reported. Our present study found CUL4B was upregulated in ccRCC, and CUL4B knockdown markedly inhibited ccRCC cell growth and induced apoptosis. In addition, CUL4B knockdown markedly inhibited antiapoptotic proteins' expression in ccRCC cells, including Mcl-1 and Bcl-2, and silenced CUL4B also induced the cleavages of PARP, an important index of apoptosis. We also confirmed microRNA-217 (miR-217) was downregulated in ccRCC tumor tissues, and negatively correlated with CUL4B expression. Further investigations revealed miR-217 targeted CUL4B and markedly inhibited its expression in ccRCC cells. In addition, overexpression of miR-217 by mimics significantly suppressed ccRCC cell growth. In contrast, enforced expression of CUL4B significantly abolished miR-217-induced cell survival inhibition in ccRCC cells. In conclusion, our present results suggested targeting miR-217-CUL4B axis would be a promising strategy for ccRCC treatment.

摘要

据报道,Cullin 4B(CUL4B)与某些肿瘤的进展密切相关,但其在透明细胞肾细胞癌(ccRCC)中的功能尚未见报道。我们目前的研究发现CUL4B在ccRCC中上调,敲低CUL4B可显著抑制ccRCC细胞生长并诱导细胞凋亡。此外,敲低CUL4B可显著抑制ccRCC细胞中抗凋亡蛋白的表达,包括Mcl-1和Bcl-2,沉默CUL4B还可诱导PARP的裂解,这是细胞凋亡的一个重要指标。我们还证实,微小RNA-217(miR-217)在ccRCC肿瘤组织中表达下调,且与CUL4B表达呈负相关。进一步研究发现,miR-217靶向CUL4B并显著抑制其在ccRCC细胞中的表达。此外,通过模拟物过表达miR-217可显著抑制ccRCC细胞生长。相反,强制表达CUL4B可显著消除miR-217诱导的ccRCC细胞存活抑制。总之,我们目前的结果表明,靶向miR-217-CUL4B轴可能是一种有前景的ccRCC治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/8b6ad482795f/KJM2-37-121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/a090c5f9a086/KJM2-37-121-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/891d48147955/KJM2-37-121-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/070d3cd12ea8/KJM2-37-121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/471f48778862/KJM2-37-121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/8b6ad482795f/KJM2-37-121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/a090c5f9a086/KJM2-37-121-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/891d48147955/KJM2-37-121-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/070d3cd12ea8/KJM2-37-121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/471f48778862/KJM2-37-121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be7f/11896321/8b6ad482795f/KJM2-37-121-g001.jpg

相似文献

1
Cullin 4B regulates cell survival and apoptosis in clear cell renal cell carcinoma as a target of microRNA-217.作为微小RNA-217的靶点,Cullin 4B调节肾透明细胞癌中的细胞存活和凋亡。
Kaohsiung J Med Sci. 2021 Feb;37(2):121-127. doi: 10.1002/kjm2.12307. Epub 2020 Oct 6.
2
Circ_0003520/miR-205-5p/CUL4B Axis Drives the Progression of Clear Cell Renal Carcinoma.环状RNA_0003520/微小RNA-205-5p/泛素连接酶E3组分C4B轴驱动透明细胞肾细胞癌进展
J Biochem Mol Toxicol. 2025 May;39(5):e70263. doi: 10.1002/jbt.70263.
3
Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.探讨长链非编码 RNA MEG3 通过调控 miR-7/RASL11B 信号通路影响肾透明细胞癌的作用机制。
J Cell Physiol. 2018 Dec;233(12):9503-9515. doi: 10.1002/jcp.26849. Epub 2018 Jul 3.
4
MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.微小RNA-185通过直接靶向血管内皮生长因子A(VEGFA)抑制VHL基因失活的透明细胞肾细胞癌的细胞增殖并诱导细胞凋亡。
Urol Oncol. 2015 Apr;33(4):169.e1-11. doi: 10.1016/j.urolonc.2015.01.003. Epub 2015 Feb 17.
5
Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.透明细胞肾细胞癌中miR-181a的上调与KLF6表达降低、细胞增殖增强、细胞周期过渡加速及细胞凋亡减少有关。
Urol Oncol. 2018 Mar;36(3):93.e23-93.e37. doi: 10.1016/j.urolonc.2017.09.019. Epub 2017 Oct 21.
6
LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.LINC00511通过吸附微小RNA-625促进肾透明细胞癌的恶性表型,从而增加细胞周期蛋白D1的表达。
Aging (Albany NY). 2019 Aug 21;11(16):5975-5991. doi: 10.18632/aging.102156.
7
MiR-30a suppresses clear cell renal cell carcinoma proliferation and metastasis by targeting LRP6.miR-30a 通过靶向 LRP6 抑制肾透明细胞癌细胞的增殖和转移。
Hum Cell. 2021 Mar;34(2):598-606. doi: 10.1007/s13577-020-00472-1. Epub 2021 Jan 5.
8
CUL4B promotes aggressive phenotypes of renal cell carcinoma via upregulating c-Met expression.CUL4B 通过上调 c-Met 表达促进肾细胞癌的侵袭表型。
Int J Biochem Cell Biol. 2021 Jan;130:105887. doi: 10.1016/j.biocel.2020.105887. Epub 2020 Nov 20.
9
MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.miR-182-5p 通过抑制 UBE2T 抑制肾透明细胞癌的肿瘤发生。
Hum Cell. 2022 Mar;35(2):542-556. doi: 10.1007/s13577-021-00661-6. Epub 2022 Feb 7.
10
Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.ACHN 细胞来源的外泌体 microRNA-15a 通过 BTG2/PI3K/AKT 轴加重肾透明细胞癌。
Kaohsiung J Med Sci. 2021 Nov;37(11):973-982. doi: 10.1002/kjm2.12428. Epub 2021 Aug 1.

引用本文的文献

1
Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.长链非编码 RNA ARAP1-AS1 通过 miR-361-3p/胎盘生长因子轴促进肾透明细胞癌中的细胞增殖和迁移。
Bioengineered. 2021 Dec;12(1):6629-6642. doi: 10.1080/21655979.2021.1975019.
2
Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma.循环 microRNAs 从分子机制到临床生物标志物:以透明细胞肾细胞癌为例。
Genes (Basel). 2021 Jul 28;12(8):1154. doi: 10.3390/genes12081154.

本文引用的文献

1
CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer.在结直肠癌中,CUL4B通过抑制肿瘤抑制因子miR34a来促进癌症干性。
Oncogenesis. 2020 Feb 13;9(2):20. doi: 10.1038/s41389-020-0206-3.
2
Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression.环状 RNA ZFR 通过作为 miR-101-3p 的海绵来增强 CUL4B 表达,从而促进非小细胞肺癌的进展。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3410-3416. doi: 10.1080/21691401.2019.1652623.
3
CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression.
CUL4B/miR-33b/C-MYC 轴促进前列腺癌进展。
Prostate. 2019 Apr;79(5):480-488. doi: 10.1002/pros.23754. Epub 2019 Jan 4.
4
The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.Cullin 4 家族 E3 连接酶在肿瘤发生中的新兴作用。
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):138-159. doi: 10.1016/j.bbcan.2018.11.007. Epub 2018 Dec 30.
5
miR‑381 and miR‑489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/β‑catenin pathway in gastric cancer.miR-381 和 miR-489 通过靶向 CUL4B 抑制胃癌细胞增殖和侵袭并调控 Wnt/β-连环蛋白通路。
Int J Oncol. 2019 Feb;54(2):733-743. doi: 10.3892/ijo.2018.4646. Epub 2018 Nov 26.
6
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.2018 年转移性透明细胞肾细胞癌的系统治疗:当前范例、免疫治疗的应用及未来方向。
Eur Urol. 2019 Jan;75(1):100-110. doi: 10.1016/j.eururo.2018.10.010. Epub 2018 Oct 13.
7
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.透明细胞肾细胞癌的系统治疗耐药:机制与管理策略。
Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299.
8
Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma.PBRM1和BAP1蛋白表达同时缺失在透明细胞肾细胞癌早期阶段的预后影响
Urol Oncol. 2018 May;36(5):243.e1-243.e8. doi: 10.1016/j.urolonc.2018.01.002. Epub 2018 Feb 14.
9
CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.CUL4B 通过 Wnt/β-连环蛋白信号通路诱导上皮-间充质转化促进胰腺癌转移和增殖。
J Cell Biochem. 2018 Jul;119(7):5308-5323. doi: 10.1002/jcb.26643. Epub 2018 Mar 14.
10
Intracellular protein degradation: From a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.细胞内蛋白质降解:从一个模糊的概念,历经溶酶体和泛素-蛋白酶体系统,直至人类疾病与药物靶点。
Best Pract Res Clin Haematol. 2017 Dec;30(4):341-355. doi: 10.1016/j.beha.2017.09.001. Epub 2017 Sep 22.